Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-18T16:20:14.930Z Has data issue: false hasContentIssue false
  • English
  • Français

Veterinary vaccines against toxoplasmosis

Published online by Cambridge University Press:  07 May 2014

ELŻBIETA HISZCZYŃSKA-SAWICKA ,
JUSTYNA M. GATKOWSKA ,
MARCIN M. GRZYBOWSKI  and
HENRYKA DŁUGOŃSKA
ELŻBIETA HISZCZYŃSKA-SAWICKA
Affiliation:
AgResearch, Private Bag 4749, Christchurch, New Zealand
JUSTYNA M. GATKOWSKA
Affiliation:
Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Łódź, Banacha St. 12/16, Poland
MARCIN M. GRZYBOWSKI
Affiliation:
Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Łódź, Banacha St. 12/16, Poland
HENRYKA DŁUGOŃSKA*
Affiliation:
Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Łódź, Banacha St. 12/16, Poland
*
* Corresponding author: Department of Immunoparasitology, University of Łódź, Banacha St. 12/16, Poland. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

Toxoplasma gondii is a cosmopolitan protozoan parasite that infects a wide range of mammal and bird species. Common infection leads to high economic (e.g. abortions in sheep) and human (e.g. congenital toxoplasmosis or neurotoxoplasmosis in humans) losses. With one exception (Toxovax™ for sheep), there are no vaccines to prevent human or animal toxoplasmosis. The paper presents the current state and challenges in the development of a vaccine against toxoplasmosis, designed for farm animals either bred for consumption or commonly kept on farms and involved in parasite transmission. So far, the trials have mostly revolved around conventional vaccines and, compared with the research using laboratory animals (mainly mice), they have not been very numerous. However, the results obtained are promising and could be a good starting point for developing an effective vaccine to prevent toxoplasmosis.

Keywords

T. gondiivaccinefarm animals
Type
Special Issue Article
Information
Parasitology , Volume 141 , Special Issue 11: ApiCOWplexa 2013 – 2nd International Meeting on Apicomplexan Parasites in Farm Animals , September 2014 , pp. 1365 - 1378
Check for updates
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Abi Abdallah, D. S., Lin, C., Ball, C. J., King, M. R., Duhamel, G. E. and Denkers, E. (2012). Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infection and Immunity 80, 768–777. doi: 10.1128/IAI.05730-11.CrossRefGoogle ScholarPubMed
Bhadra, R. and Khan, I. A. (2013). Redefining chronic toxoplasmosis – a T cell exhaustion perspective. PLoS Pathogens 8, e1002903. doi: 10.1371/journal.ppat.1002903.Google Scholar
Bhadra, R., Gigley, J. P. and Khan, I. A. (2011). The CD8T-cell road to immunotherapy of toxoplasmosis. Immunotherapy 3, 789–801. doi: 10.2217/imt.11.68.Google Scholar
Blanchard, N., Gonzales, F., Schaeffer, M., Joncker, N. T., Cheng, T., Shastri, A. J., Robey, E. A. and Ahastri, N. (2008). Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 9, 937–944. doi: 10.1038/ni.1629.Google Scholar
Booth, K. S., James, E. R. and Popiel, I. (1996). Cryopreservation of an attenuated vaccine strain of the protozoan parasite Toxoplasma gondii . Cryobiology 33, 330–337.Google Scholar
Boothroyd, J. C. (2009). Expansion of host range as a driving force in the evolution of Toxoplasma gondii . Memórias do Instituto Oswaldo Cruz 104, 179–184. doi: 10.1590/S0074-02762009000200009.CrossRefGoogle Scholar
Buxton, D. and Innes, E. A. (1995). A commercial vaccine for ovine toxoplasmosis. Parasitology 110(Suppl.), S11–S16.Google Scholar
Buxton, D., Thomson, K., Maley, S., Wright, S. and Bos, H. J. (1991). Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Veterinary Record 129, 89–93.CrossRefGoogle ScholarPubMed
Buxton, D., Thomson, K. M., Maley, S., Wright, S. and Bos, H. J. (1993). Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Veterinary Record 133, 310–312.Google Scholar
Buxton, D., Maley, S. W., Wright, S. E., Rodger, S., Bartley, P. and Innes, E. A. (2007). Toxoplasma gondii and ovine toxoplasmosis: new aspects of an old story. Veterinary Parasitology 149, 25–28.CrossRefGoogle ScholarPubMed
Conde, M., Caballero, J. M., Rodriguez-Ponce, E., Ruiz, A. and Gonzalez, J. (2001). Analysis of IgG response to experimental infection with RH Toxoplasma gondii in goats. Comparative Immunology, Microbiology and Infectious Diseases 24, 197–206.CrossRefGoogle ScholarPubMed
Conde de Felipe, M. M., Molina, J. M., Rodriguez-Ponce, E., Ruiz, A. and Gonzalez, J. F. (2007). IgM and IgG response to 29–35-kDa Toxoplasma gondii protein fractions in experimentally infected goats. Journal of Parasitology 93, 701–703.CrossRefGoogle ScholarPubMed
Crampton, A. and Vanniasinkam, T. (2007). Parasite vaccines: the new generation. Infection, Genetics and Evolution 7, 664–673.Google Scholar
da Cunha, I. A., Zulpo, D. L., Bogado, A. L., de Barros, L. D., Taroda, A., Igarashi, M., Navarro, I. T. and Garcia, J. L. (2012). Humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of Toxoplasma gondii plus Quil-A. Veterinary Parasitology 186, 216–221. doi: 10.1016/j.vetpar.2011.11.034.CrossRefGoogle ScholarPubMed
Demar, M., Ajzenberg, D., Maubon, D., Djossou, F., Panchoe, D., Punwasi, W., Valery, N., Peneau, C., Daigre, J. L., Aznar, C., Cotrelle, B., Terzan, L., Dardé, M. L. and Carme, B. (2007). Fatal outbreak of human toxoplasmosis along the Maroni river: epidemiological, clinical, and parasitological aspects. Clinical Infectious Diseases 45, e88–e96. doi: 10.1086/521246.Google Scholar
Di Cristina, M., Del Porto, P., Buffolano, W., Beghetto, E., Spadoni, A., Guglietta, S., Piccolella, E., Felici, F. and Gargano, N. (2004). The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes and Infection 6, 164–171.Google Scholar
Dimier-Poisson, I., Aline, F., Bout, D. and Mevelec, M. N. (2006). Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA. Vaccine 24, 1705–1709.Google Scholar
Dubey, J. P. (1996). Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Veterinary Parasitology 64, 65–70.CrossRefGoogle ScholarPubMed
Dubey, J. P. (2007). The history and life cycle of Toxoplasma gondii . In Toxoplasma gondii: the Model Apicomplexan – Perspectives and Methods (ed. Weiss, L. M. and Kim, K.), pp. 1–17. Elsevier, London, UK.Google Scholar
Dubey, J. P. (2009). Toxoplasmosis in pigs – the last 20 years. Veterinary Parasitology 164, 89–103. doi: 10.1016/j.vetpar.2009.05.018.Google Scholar
Dubey, J. P. (2010). Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis and public health significance. Zoonoses and Public Health 57, 60–73. doi: 10.1111/j.1863-2378.2009.01274.x.CrossRefGoogle ScholarPubMed
Dubey, J. P. and Jones, J. L. (2008). Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology 38, 1257–1278. doi: 10.1016/j.ijpara.2008.03.007.Google Scholar
Dubey, J. P. and Prowell, M. (2013). Ante-mortem diagnosis, diarrhea, oocyst shedding, treatment, isolation, and genetic typing of Toxoplasma gondii associated with clinical toxoplasmosis in a naturally infected cat. Journal of Parasitology 99, 158–160. doi: 10.1645/GE-3257.1.Google Scholar
Dubey, J. P., Miller, N. L. and Frenkel, J. K. (1970). The Toxoplasma gondii oocyst from cat feces. Journal of Experimental Medicine 132, 636–662.CrossRefGoogle ScholarPubMed
Dubey, J. P., Urban, J. F. Jr. and Davis, S. W. (1991). Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii . American Journal of Veterinary Research 52, 1316–1319.Google Scholar
Dubey, J. P., Baker, D. G., Davis, S. W., Urban, J. F. Jr. and Shen, S. K. (1994). Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii . American Journal of Veterinary Research 55, 982–987.Google Scholar
Dubey, J. P., Lunney, J. K., Shen, S. K. and Kwok, O. C. (1998). Immunity to toxoplasmosis in pigs fed irradiated Toxoplasma gondii oocysts. Journal of Parasitology 84, 749–752.Google Scholar
Dubey, J. P., Hill, D. E., Jones, J. L., Hightower, A. W., Kirkland, E., Roberts, J. M., Marcet, P. L., Lehmann, T., Vianna, M. C., Miska, K., Sreekumar, C., Kwok, O. C., Shen, S. K. and Gamble, H. R. (2005). Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. Journal of Parasitology 91, 1082–1093.Google Scholar
Dubey, J. P., Rajendran, C., Ferreira, L. R., Martins, J., Kwok, O. C. H., Hill, D. E., Villena, I., Zhou, H., Su, C. and Jones, J. L. (2011). High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA. International Journal for Parasitology 41, 827–833. doi: 10.1016/j.ijpara.2011.03.006.CrossRefGoogle ScholarPubMed
Dupont, C. D., Christian, D. A. and Hunter, C. A. (2012). Immune response and immunopathology during toxoplasmosis. Seminars in Immunopathology 34, 793–813. doi: 10.1007/s00281-012-0339-3.Google Scholar
Elmore, S. A., Jones, J. L., Conrad, P. A., Patton, S., Lindsay, D. S. and Dubey, J. P. (2010). Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology 26, 190–196. doi: 10.1016/j.pt.2010.01.009.CrossRefGoogle ScholarPubMed
Falcon, J. and Freyre, A. (2009). Toxoplasma gondii: prototype immunization of lambs against formation of muscle and brain cysts. Veterinary Parasitology 166, 15–20. doi: 10.1016/j.vetpar.2009.08.012.Google Scholar
Feliu, V., Vasseur, V., Grover, H. S., Chu, H. H., Brown, M. J., Wang, J., Boyle, J. P., Robey, E. A., Shastri, N. and Blanchard, N. (2013). Location of the CD8T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathogens 9, e1003449. doi: 10.1371/journal.ppat.1003449.Google Scholar
Frenkel, J. K., Pfefferkorn, E. R., Smith, D. D. and Fishback, J. L. (1991). Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats. American Journal of Veterinary Research 52, 759–763.Google Scholar
Freyre, A., Choromanski, L., Fishback, J. L. and Popiel, I. (1993). Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii . Journal of Parasitology 79, 716–719.Google Scholar
Freyre, A., Falcón, J., Méndez, J., Gastell, T. and Venzal, J. M. (2007). Toxoplasma gondii: cross-immunity against the enteric cycle. Experimental Parasitology 115, 48–52.Google Scholar
Garcia, J. L., Gennari, S. M., Navarro, I. T., Machado, R. Z., Sinhorini, I. L., Freire, R. L., Marana, E. R., Tsutsui, V., Contente, A. P. and Begale, L. P. (2005). Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii . Veterinary Parasitology 129, 209–217.Google Scholar
Garcia, J. L., Navarro, I. T., Biazzono, L., Freire, R. L., da Silva Guimarães Junior, J., Cryssafidis, A. L., Bugni, F. M., da Cunha, I. A., Hamada, F. N. and Dias, R. C. (2007). Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route. Veterinary Parasitology 145, 197–206.Google Scholar
Gatkowska, J., Wieczorek, M., Dziadek, B., Dzitko, K. and Długońska, H. (2012). Behavioral changes in mouse caused by Toxoplasma gondii invasion of brain. Parasitology Research 111, 53–58. doi: 10.1007/s00436-011-2800-y.Google Scholar
Hill, D. E. and Dubey, J. P. (2013). Toxoplasma gondii prevalence in farm animals in the United States. International Journal for Parasitology 43, 107–113. doi: 10.1016/j.ijpara.2012.09.012.Google Scholar
Hiszczynska-Sawicka, E., Li, H., Xu, J. B., Oledzka, G., Kur, J., Bickerstaffe, R. and Stankiewicz, M. (2010 a). Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Experimental Parasitology 124, 365–372. doi: 10.1016/j.exppara.2009.11.015.Google Scholar
Hiszczynska-Sawicka, E., Akhtar, M., Kay, G. W., Holec-Gasior, L., Bickerstaffe, R., Kur, J. and Stankiewicz, M. (2010 b). The immune responses of sheep after DNA immunization with, Toxoplasma gondii MAG1 antigen-with and without co-expression of ovine interleukin 6. Veterinary Immunology and Immunopathology 136, 324–329. doi: 10.1016/j.vetimm.2010.03.018.CrossRefGoogle ScholarPubMed
Hiszczynska-Sawicka, E., Oledzka, G., Holec-Gasior, L., Li, H., Xu, J. B., Sedcole, R., Kur, J., Bickerstaffe, R. and Stankiewicz, M. (2011 a). Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii . Veterinary Parasitology 177, 281–289. doi: 10.1016/j.vetpar.2010.11.047.Google Scholar
Hiszczynska-Sawicka, E., Li, H., Xu, J. B., Holec-Gasior, L., Kur, J., Sedcole, R., Bickerstaffe, R. and Stankiewicz, M. (2011 b). Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Veterinary Parasitology 183, 72–78. doi: 10.1016/j.vetpar.2011.06.010.Google Scholar
Hiszczynska-Sawicka, E., Li, H., Boyu Xu, J., Akhtar, M., Holec-Gasior, L., Kur, J., Bickerstaffe, R. and Stankiewicz, M. (2012). Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene. Polish Journal of Veterinary Sciences 15, 3–9.CrossRefGoogle ScholarPubMed
Howard, J. C., Hunn, J. P. and Steinfeldt, T. (2011). The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii . Current Opinion in Microbiology 14, 414–421. doi: 10.1016/j.mib.2011.07.002.Google Scholar
Innes, E. A., Bartley, P. M., Buxton, D. and Katzer, F. (2009 a). Ovine toxoplasmosis. Parasitology 136, 1887–1894. doi: 10.1017/S0031182009991636.Google Scholar
Innes, E. A., Bartley, P. M., Maley, S., Katzer, F., and Buxton, D. (2009 b). Veterinary vaccines against Toxoplasma gondii . Memórias do Instituto Oswaldo Cruz 104, 246–251. doi: 10.1590/S0074-02762009000200018.Google Scholar
Jenkins, M. C. (2001). Advances and prospects for subunit vaccines against protozoa of veterinary importance. Veterinary Parasitology 101, 291–310.Google Scholar
Jones, J. L. and Holland, G. N. (2010). Annual burden of ocular toxoplasmosis in the US. American Journal of Tropical Medicine and Hygiene 82, 464–465. doi: 10.4269/ajtmh.2010.09-0664.Google Scholar
Jongert, E., Melkebeek, V., De Craeye, S., Dewit, J., Verhelst, D. and Cox, E. (2008). An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 26, 1025–1031. doi: 10.1016/j.vaccine.2007.11.058.Google Scholar
Jongert, E., Roberts, C. W., Gargano, N., Förster-Waldi, E. and Petersen, E. (2009). Vaccines against Toxoplasma gondii: challenges and opportunities. Memórias do Instituto Oswaldo Cruz 104, 252–266. doi: 10.1590/S0074-02762009000200019.Google Scholar
Katzer, F., Bruelisauer, F., Collantes-Fernández, E., Bartley, PM, Burrells, A., Gunn, G., Maley, S. W., Cousens, C. and Innes, E. A. (2011). Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection. Veterinary Research 42, 121–129. doi: 10.1186/1297-9716-42-121.Google Scholar
Kijlstra, A. and Jongert, E. (2009). Toxoplasma-safe meat: close to reality? Trends in Parasitology 25, 18–22. doi: 10.1016/j.pt.2008.09.008.CrossRefGoogle ScholarPubMed
Koneswaran, G. and Nierenberg, D. (2008). Global farm animal production and global warming: impacting and mitigating climate change. Environmental Health Perspectives 116, 578–582. doi: 10.1289/ehp.11034.Google Scholar
Koshy, A. A., Dietrich, H. K., Christian, D. A., Melehani, J. H., Shastri, A. J., Hunter, C. A. and Boothroyd, J. C. (2012). Toxoplasma co-opts host cells it does not invade. PLoS Pathogens 8, e1002825. doi: 10.1371/journal.ppat.1002825.Google Scholar
Kringel, H., Dubey, J. P., Beshah, E., Hecker, R. and Urban, J. F. Jr. (2004). CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii . Veterinary Parasitology 123, 55–66.Google Scholar
Kur, J., Holec-Gąsior, L. and Hiszczyńska-Sawicka, E. (2009). Current status of toxoplasmosis vaccine development. Expert Review of Vaccines 8, 791–808. doi: 10.1586/erv.09.27.Google Scholar
Laliberté, J. and Carruthers, V. B. (2008). Host cell manipulation by the human pathogen Toxoplasma gondii . Cellular and Molecular Life Sciences 65, 1900–1915. doi: 10.1007/s00018-008-7556-x.Google Scholar
Letscher-Bru, V., Pfaff, A. W., Abou-Bacar, A., Filisetti, D., Antoni, E., Villard, O., Klein, J. P. and Candolfi, E. (2003). Vaccination with Toxoplasma gondii SAG-1 protection is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infection and Immunity 71, 6615–6619. doi: 10.1128/IAI.71.11.6615-6619.2003.Google Scholar
Li, B., Oledzka, G., McFarlane, R. G., Spellerberg, M. B., Smith, S. M., Gelder, F. B., Kur, J. and Stankiewicz, M. (2010). Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes. Parasite Immunology 32, 671–683. doi: 10.1111/j.1365-3024.2010.01228.x.Google Scholar
Lindsay, D. S., Blagburn, B. L. and Dubey, J. P. (1993). Safety and results of challenge of weaned pigs given a temperature-sensitive mutant of Toxoplasma gondii . Journal of Parasitology 79, 71–76.CrossRefGoogle Scholar
Lindsay, D. S., Dubey, J. P., Butler, J. M. and Blagburn, B. L. (1997). Mechanical transmission of Toxoplasma gondii oocysts by dogs. Veterinary Parasitology 73, 27–33.Google Scholar
Liu, Q., Singla, L. D. and Zhou, H. (2012). Vaccines against Toxoplasma gondii: status, challenges and future directions. Human Vaccines and Immunotherapeutics 8, 1305–1308. doi: 10.4161/hv.21006.Google Scholar
Lunden, A. (1995). Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Veterinary Parasitology 56, 23–35.Google Scholar
Mateus-Pinilla, N. E., Dubey, J. P., Choromanski, L. and Weigel, R. M. (1999). A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. Journal of Parasitology 85, 855–860.Google Scholar
Mateus-Pinilla, N. E., Hannon, B. and Weigel, R. M. (2002). A computer simulation of the prevention of the transmission of Toxoplasma gondii on swine farms using a feline T. gondii vaccine. Preventive Veterinary Medicine 55, 17–36.CrossRefGoogle ScholarPubMed
McConkey, G. A., Martin, H. L., Bristow, G. and Webster, J. P. (2013). Toxoplasma gondii infection and behavior – location, location, location? Journal of Experimental Biology 216, 113–119. doi: 10.1242/jeb.074153.Google Scholar
Menzies, P. I. (2012). Vaccination programs for reproductive disorders of small ruminants. Animal Reproduction Science 130, 162–172. doi: 10.1016/j.anireprosci.2012.01.010.Google Scholar
Mevelec, M. N., Ducournau, C., Bassuny Ismael, A., Olivier, M., Seche, E., Lebrun, M., Bout, D. and Dimier-Poisson, I. (2010). Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep. Veterinary Research 41, 41–49. doi: 10.1051/vetres/2010021.Google Scholar
Miller, C. M., Boulter, N. R., Ikin, R. J. and Smith, N. C. (2009). The immunobiology of the innate response to Toxoplasma gondii . International Journal for Parasitology 39, 23–39. doi: 10.1016/j.ijpara.2008.08.002.Google Scholar
Mishima, M., Xuan, X., Yokoyama, N., Igarashi, I., Fujisaki, K., Nagasawa, H. and Mikami, T. (2002). Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitology Research 88, 144–149.Google Scholar
Montoya, J. G. and Liesenfeld, O. (2004). Toxoplasmosis. Lancet 363, 1965–1976.Google Scholar
Munoz, M., Liesenfeld, O. and Heimesaat, M. M. (2011). Immunology of Toxoplasma gondii . Immunological Reviews 240, 269–285. doi: 10.1111/j.1600-065X.2010.00992.x.Google Scholar
O'Connell, E., Wilkins, M. F. and Te Punga, W. A. (1988). Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii . New Zealand Veterinary Journal 36, 1–4.Google Scholar
Omata, Y., Aihara, Y., Kanda, M., Saito, A., Igarashi, I. and Suzuki, N. (1996). Toxoplasma gondii: experimental infection in cats vaccinated with 60Co-irradiated tachyzoites. Veterinary Parasitology 65, 173–183.Google Scholar
Opsteegh, M., Teunis, P., Züchner, L., Koets, A., Langelaar, M. and van der Giessen, J. (2011). Low predictive value of seroprevalence of Toxoplasma gondii in cattle for detection of parasite DNA. International Journal for Parasitology 41, 343–354. doi: 10.1016/j.ijpara.2010.10.006.CrossRefGoogle ScholarPubMed
Patronov, A. and Doytchinova, I. (2012). T-cell epitope vaccine design by immunoinformatics. Open Biology 3, 120139. doi: 10.1098/rsob.120139.Google Scholar
Pinckney, R. D., Lindsay, D. S., Blagburn, B. L., Boosinger, T. R., McLaughlin, S. A. and Dubey, J. P. (1994). Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii . Journal of Parasitology 80, 438–448.Google Scholar
Prandota, J. (2012). Gastrointestinal tract abnormalities in autism, inflammatory bowel disease and many other clinical entities may be due to T. gondii infection. Scientific Reports 1, 256. doi: 10.4172/scientific reports.256.Google Scholar
Robben, P. M., Mordue, D. G., Truscott, S. M., Takeda, K., Akira, S. and Sibley, L. D. (2004). Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. Journal of Immunology 172, 3686–3694. doi: jimmunol.org/content/172/6/3686.Google Scholar
Rueckert, C. and Guzmán, C. A. (2012). Vaccines: from empirical development to rational design. PLoS Pathogens 8, e1003001. doi: 10.1371/journal.ppat.1003001.Google Scholar
Schaap, D., Vermeulen, A. N., Roberts, C. W. and Alexander, J. (2007). Vaccination against toxoplasmosis: current status and future prospects. In Toxoplasma gondii: The Model Apicomplexan – Perspectives and Methods (ed. Weiss, L. M. and Kim, K.), pp. 721–759. Elsevier, London, UK.Google Scholar
Stanley, A. C., Buxton, D., Innes, E. A. and Huntley, J. F. (2004). Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine 22, 3929–3941.Google Scholar
Stormoen, M., Tharaldsen, J. and Hopp, P. (2012). Seroprevalence of Toxoplasma gondii infection in Norwegian dairy goats. Acta Veterinaria Scandinavica 54, 75–77. doi: 10.1186/1751-0147-54-75.Google Scholar
Supply, P., Sutton, P., Coughlan, S. N., Bilo, K., Saman, E., Trees, A. J., Cesbron Delauw, M. F. and Locht, C. (1999). Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii . Vaccine 17, 705–714.Google Scholar
Tonelli, R. R., Colli, W. and Alves, M. J. M. (2013). Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro . Frontiers in Immunology 3, 419. doi: 10.3389/fimmu.2012.00419.CrossRefGoogle ScholarPubMed
Tzanidakis, N., Maksimov, P., Conraths, F. J., Kiossis, E., Brozos, C., Sotiraki, S. and Schares, G. (2012). Toxoplasma gondii in sheep and goats: seroprevalence and potential risk factors under dairy husbandry practices. Veterinary Parasitology 190, 340–348.Google Scholar
Vercruysse, J., Schetters, T. P., Knox, D. P., Willadsen, P. and Clarebout, E. (2007). Control of parasitic disease using vaccines: an answer to drug resistance? Scientific and Technical Review 26(1), 105–115.Google Scholar
Wang, Y., Zhang, D., Wang, G., Yin, H. and Wang, M. (2013). Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs. Parasitology Research 112, 3835–3842. doi: 10.1007/s00436-013-3571-4.Google Scholar
Wilkins, M. F., O'Connell, E. and Te Punga, W. A. (1988). Toxoplasmosis in sheep. III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. New Zealand Veterinary Journal 36, 86–89.Google Scholar
Wolff, J. A. and Budker, V. (2005). The mechanism of naked DNA uptake and expression. Advances in Genetics 54, 3–20.Google Scholar
Yarovinsky, F. (2008). Toll-like receptors and their role in host resistance to Toxoplasma gondii . Immunology Letters 119, 17–21. doi: 10.1016/j.imlet.2008.05.007.Google Scholar
Zhang, N. Z., Chen, J., Wang, M., Petersen, E. and Zhu, X. Q. (2013). Vaccines against Toxoplasma gondii: new development and perspectives. Expert Review of Vaccines 12, 1287–1299. doi: 10.1586/14760584.2013.844652.Google Scholar
Zhao, G., Zhou, A., Lu, G., Meng, M., Sun, M., Bai, Y., Han, Y., Wang, L., Zhou, H., Cong, H., Zhao, Q., Zhu, X. Q. and He, S. (2013). Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis. Parasites and Vectors 6, 175. doi: 10.1186/1756-3305-6-175.CrossRefGoogle ScholarPubMed
Zulpo, D. L., Headley, S. A., Biazzono, L., da Cunha, I. A., Igarashi, M., de Barros, L. D., Taroda, A., Cardim, S. T., Bogado, A. L., Navarro, I. T. and Garcia, J. L. (2012). Oocyst shedding in cats vaccinated by the nasal and rectal routes with crude rhoptry proteins of Toxoplasma gondii . Experimental Parasitology 131, 223–230. doi: 10.1016/j.exppara.2012.04.006.Google Scholar